Eventide Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.1M | Sell |
|
|||||
|
2025
Q1 | $44.9M | Sell |
|
|||||
|
2024
Q4 | $56.6M | Buy |
|
|||||
|
2024
Q3 | $61.7M | Buy |
|
|||||
|
2024
Q2 | $21.1M | Hold |
|
|||||
|
2024
Q1 | $13M | Hold |
|
|||||
|
2023
Q4 | $16.7M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $5.43M | Hold |
|
|||||
|
2018
Q2 | $6.11M | Hold |
|
|||||
|
2018
Q1 | $7.38M | Sell |
|
|||||
|
2017
Q4 | $11.4M | Hold |
|
|||||
|
2017
Q3 | $10.6M | Hold |
|
|||||
|
2017
Q2 | $7.18M | Hold |
|
|||||
|
2017
Q1 | $4.61M | Hold |
|
|||||
|
2016
Q4 | $3.37M | Hold |
|
|||||
|
2016
Q3 | $6.1M | Hold |
|
|||||
|
2016
Q2 | $4.99M | Hold |
|
|||||
|
2016
Q1 | $5.65M | Hold |
|
|||||
|
2015
Q4 | $8.47M | Buy |
|
|||||
|
2015
Q3 | $5.68M | Buy |
|
|||||
|
2015
Q2 | $5.45M | Buy |
|
|||||
|
2015
Q1 | $4.38M | Buy |
|